Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry
Cornelia Voigt-Müller, Michelle Pfaffenlehner, Günther Bernert, Hakan Çetin et autres
2 citationsBrain
Julia Bellut
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
255Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Neurogenetic and Muscular Disorders ResearchCardiomyopathy and Myosin StudiesSpinal Dysraphism and MalformationsCongenital Anomalies and Fetal SurgeryAmyotrophic Lateral Sclerosis Research
Publications récentes
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study
Claudia D. Wurster, Benjamin Stolte, Tobias Keßler, Maren Freigang et autres
1 citationOrphanet Journal of Rare Diseases
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, Max Behrens et autres
70 citationsArchives of Pediatrics and Adolescent Medicine
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
René Günther, Claudia D. Wurster, Svenja Brakemeier, Alma Osmanovic et autres
65 citationsThe Lancet Regional Health - Europe
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, Adrian Tassoni et autres
42 citationsOrphanet Journal of Rare Diseases
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
Astrid Pechmann, Max Behrens, Katharina Dörnbrack, Adrian Tassoni et autres
75 citationsBrain
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.